Individualizing Incretin-Based Therapy in Cardiovascular-Kidney-Metabolic (CKM) Syndrome

60-minute Program
Effective dates for CE credit: 11/11/2026 – 11/11/2027

Program Overview

Incretin-based therapies have an expanding role in the management of cardiovascular-kidney-metabolic (CKM) syndrome, including type 2 diabetes, obesity, cardiovascular disease, and chronic kidney disease. This activity will review the impact of the incretin system on CKM syndrome and examine the role of incretin-based therapies in the management of CKM-related chronic conditions. Participants will review the different classes of incretin-based therapies, approved indications, and considerations for medication selection and use. The activity will also describe the role of the diabetes care and education specialist (DCES) in supporting medication selection, dosing adjustments, adverse effect management, and patient education.

Learning Outcome

DCESs and other healthcare team members will be able to apply evidence-based considerations for incretin-based therapy selection, initiation, dose titration, adverse effect management, and patient education to support individualized care for people with CKM syndrome.

Learning Objectives

At the end of this presentation, participants will be able to:
1. Explain the role of the incretin system in cardiovascular-metabolic-kidney (CKM) syndrome.
2. Differentiate incretin-based therapy classes by approved indications, expected benefits, safety considerations, and patient selection factors.
3. Discuss the role of the diabetes care and education specialist (DCES) team in supporting incretin-based therapy use in people with CKM syndrome

Activity Type

This recording of a live presentation is a knowledge-based learning activity.

Learning Format

Enduring Material

Intended Audience

This activity is designed for diabetes care and education specialists, including nurses, dietitians, pharmacists, pharmacy technicians, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Originally presented on: 11/11/2026
Expiration date: 11/11/2027

Lauren Cunningham, PharmD, BCACP, CDCES
Clinical Assistant Professor
Assistant Director, PGY2 Ambulatory Care Residency Program
Department of Pharmacy Practice
College of Pharmacy
Clinical Pharmacist, Family Medicine
University of Illinois Hospital and Health Sciences System

Elizabeth Van Dril, PharmD, BCPS, BCACP, CDCES
Clinical Assistant Professor, Pharmacy Practice
University of Illinois Chicago
Retzky College of Pharmacy
Clinical Pharmacist, Internal Medicine
University of Illinois Hospital and Health Sciences System

In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.

Joint Accreditation/ACCME requires ADCES to identify and mitigate all relevant financial relationships with ineligible companies to ensure educational content is balanced, evidence-based, and free from bias. Disclosure information is provided to help learners recognize any relevant financial relationships and make their own informed judgments about the content. If you perceive any bias during the activity, please report it through the evaluation form.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:

Speakers/Planners

Lauren Cunningham, PharmD, BCACP, CDCES - Research Grant: Bayer (relationship ended)
Elizabeth Van Dril, PharmD, BCPS, BCACP, CDCES - Research Grant: Bayer (relationship ended)

Peer Reviewers

Eileen Egan, DNP, FNP, CDCES, BC-ADM, FADCES - No relevant financial relationships
Cathriya Penny, DNP, ACHPN, FNP-BC, GNP-BC, CCP, BC-ADM - No relevant financial relationships
Charles D. Ponte, BS Pharm, PharmD, BC-ADM, CDCES - No relevant financial relationships
Bau Tran, PA-C, PharmD - No relevant financial relationships
Jocelyn Protopappas, MSW, MPH, RDN - No relevant financial relationships
Tania C Bezerra, MA, RDN, LDN, CDCES - No relevant financial relationships

All relevant financial relationships have been mitigated.

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Financial Support

None

In support of improving patient care, the Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

	Accreditation Council for Pharmacy Education (ACPE) The Universal Activity Number is JA4008258-0000-26-386-H01-P; JA4008258-0000-26-386-H01-T. This knowledge-based activity has been approved for 1.0 contact hour(s). This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.
	American Medical Association (AMA) Association of Diabetes Care & Education Specialists designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
	American Nurses Credentialing Center (ANCC) Association of Diabetes Care & Education Specialists designates this activity for a maximum of 1.0 ANCC contact hour(s). This activity discusses 0.75 contact hour(s) of pharmacotherapeutic content.  The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 1.0 contact hour(s).
	American Academy of PAs (AAPA) The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit(s). Approval is valid until 11/11/27. PAs should only claim credit commensurate with the extent of their participation.

Commission on Dietetic Registration (CDR) CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education unit(s) (CPEU) for completion of this activity.  Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

Association of Social Work Boards (ASWB)  As a Jointly Accredited Organization, the Association of Diabetes Care & Education Specialists is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit(s).

Successful Completion

To receive a Statement of Credit, you must participate in all identified components of the activity and complete an evaluation.

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

Board Certified Advanced Diabetes Management (BC-ADM)

CBDCE is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.

Other Health Professionals

It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.

Members: $29.95
Non-Members: $44.95

Volume discounts are available and will be automatically applied at check-out when the desired quantity is selected
-- Groups of 4-9: 10% off
-- Groups of 10-19: 20% off
-- Groups of 20-29: 30% off
-- Groups of 30+: 40% off

ADCES CBs and LNGs: Please contact us at education@adces.org to order a recorded webinar for a group viewing.

Not an ADCES member? Join today to get discounted member pricing on all events and products!